Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058)
NCT03843632
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
150
Enrollment
INDUSTRY
Sponsor class
Conditions
Varicella
Interventions
BIOLOGICAL:
VARIVAX™
Sponsor
Merck Sharp & Dohme LLC